Q

What did the 2009 systematic review in the Annals of Internal Medicine conclude about PSA screening?

From 5 years of verified research · Vassili Sandqvist
A

The review found that PSA screening can reduce prostate cancer mortality by 20–50%, but it also highlighted significant issues with overdiagnosis and overtreatment of clinically insignificant cancers. For every death prevented, approximately 48 men may be identified and treated unnecessarily.

This is one answer. The complete system — the psychology, the biology, and the method — is in the book.

Read The Willpower Lie →
Found an error? Let me know →